Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
4D Molecular Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
4D Molecular Therapeutics

4D Molecular Therapeutics

Public

4D Molecular Therapeutics designs and commercializes gene therapy products for unmet medical needs.

HQ
Emeryville, CA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

4D Molecular Therapeutics is a biotechnology company focused on designing, developing, and commercializing transformative gene therapy products for unmet medical needs. Utilizing directed evolution, the company creates new vectors for genetic medicines, aiming to address conditions that currently lack effective treatments. Their market focus includes patients with rare and severe diseases, primarily serving customers in California.

The company has made significant strides in the field of gene therapy, leveraging advanced techniques to develop innovative solutions. Their work has garnered attention in the biotechnology community, contributing to the evolving landscape of genetic medicine. Notable affiliated individuals include Erik Allison, who plays a key role in the company's operations.

4D Molecular Therapeutics - Similar Companies

Apertura Gene Therapy logo

Apertura Gene Therapy

aperturagtx.com

C4 Therapeutics logo

C4 Therapeutics

c4therapeutics.com

Intergalactic Therapeutics logo

Intergalactic Therapeutics

Solid Biosciences logo

Solid Biosciences

solidbio.com

Dnalite Therapeutics logo

Dnalite Therapeutics

Poseida Therapeutics logo

Poseida Therapeutics

poseida.com

Sarepta Therapeutics logo

Sarepta Therapeutics

sarepta.com

Voyager Therapeutics logo

Voyager Therapeutics

Kriya Therapeutics logo

Kriya Therapeutics

Encoded Therapeutics logo

Encoded Therapeutics

Regenxbio logo

Regenxbio

regenxbio.com

Beam Therapeutics logo

Beam Therapeutics

beamtx.com

Excision BioTherapeutics logo

Excision BioTherapeutics

Dystrogen Therapeutics logo

Dystrogen Therapeutics

dystrogen.com

Code Biotherapeutics logo

Code Biotherapeutics

codebiotx.com

4D Molecular Therapeutics - Quick Facts

Who are 4D Molecular Therapeutics' competitors?

Companies similar to 4D Molecular Therapeutics include Apertura Gene Therapy, C4 Therapeutics, Intergalactic Therapeutics and Solid Biosciences.

When was 4D Molecular Therapeutics founded?

4D Molecular Therapeutics was founded in 2013.

Where is 4D Molecular Therapeutics' headquarters located?

4D Molecular Therapeutics' headquarters is located in Emeryville, CA, US.

When was 4D Molecular Therapeutics' last funding round?

4D Molecular Therapeutics' most recent funding round was for $120M (USD) in May 2023.

How much has 4D Molecular Therapeutics raised to-date?

As of May 4, 2023, 4D Molecular Therapeutics has raised a total of $295M (USD).

How many employees does 4D Molecular Therapeutics have?

4D Molecular Therapeutics has 140 employees as of Feb 6, 2024.

4D Molecular Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Gene Therapy
Tags
  • Healthtech
Unique IDs
  • secCik: 0001650648
  • ticker: FDMT
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research